日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PICO-based assessment and categorization of evidence for digital health interventions: an inductive framework development

基于PICO的数字健康干预证据评估与分类:一种归纳框架的构建

Buddrus, Uwe; Kutza, Jan-Oliver; Thye, Johannes; Esdar, Moritz; Hübner, Ursula Hertha; Liebe, Jan-David

M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

M4205 (IDRX-42) 是一种对癌症中 KIT 相关致癌驱动因子和耐药变体具有高度选择性和强效抑制作用的抑制剂

Esdar Christina, Linde Nina, Blum Andreas, Schieferstein Hanno, Drechsler Christine, Sherbetjian Eva, Petersson Carl, Ross Edith, Leuthner Birgitta, Grädler Ulrich, Dorsch Dieter, Blaukat Andree

Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer

介导激酶抑制剂在结直肠癌中的选择性和活性

Ortiz-Ruiz, Maria J; Popoola, Olajumoke; Mitsopoulos, Konstantinos; Te-Poele, Robert; Samant, Rahul S; Box, Gary; Court, Will; Brandon, Alexis De Haven; Gowan, Sharon; Mallinger, Aurelie; Roe, Toby; Swabey, Kate; Valenti, Melanie; Al-Lazikani, Bissan; Blagg, Julian; Esdar, Christina; Schiemann, Kai; Wienke, Dirk; Eccles, Suzanne A; Workman, Paul; Clarke, Paul A

Cardiac effects of 5F-Cumyl-PEGACLONE

5F-枯基-聚乙二醇酯的心脏效应

Esdar, Nicole; Pawlik, Evelyn; Eickhoff, Simon B; Raupach, Annika; Ritz-Timme, Stefanie; Mayer, Felix

Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck

抑制抑制剂:IAP抑制剂xevinapant的研发及其在治疗局部晚期头颈部鳞状细胞癌中的应用

Ferris, Robert L; Harrington, Kevin; Schoenfeld, Jonathan D; Tahara, Makoto; Esdar, Christina; Salmio, Satu; Schroeder, Andreas; Bourhis, Jean

MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core

MSC-1186,一种基于特殊修饰的苯并咪唑-嘧啶核心的高选择性 Pan-SRPK 抑制剂

Martin Schröder, Matthias Leiendecker, Ulrich Grädler, Juliane Braun, Andreas Blum, Marek Wanior, Benedict-Tilman Berger, Andreas Krämer, Susanne Müller, Christina Esdar, Stefan Knapp, Timo Heinrich

Overcoming MET-mediated resistance in oncogene-driven NSCLC

克服致癌基因驱动的非小细胞肺癌中 MET 介导的耐药性

Nadine Reischmann, Carolin Schmelas, Miguel Ángel Molina-Vila, Núria Jordana-Ariza, Daniel Kuntze, Silvia García-Roman, Manon A Simard, Doreen Musch, Christina Esdar, Joachim Albers, Niki Karachaliou

Health Information Exchange: Understanding the Policy Landscape and Future of Data Interoperability

健康信息交换:了解政策环境和数据互操作性的未来

Holmgren, A Jay; Esdar, Moritz; Hüsers, Jens; Coutinho-Almeida, João

Effects of Hospital Digitization on Clinical Outcomes and Patient Satisfaction: Nationwide Multiple Regression Analysis Across German Hospitals

医院数字化对临床结果和患者满意度的影响:德国全国医院多元回归分析

von Wedel, Philip; Hagist, Christian; Liebe, Jan-David; Esdar, Moritz; Hübner, Ursula; Pross, Christoph

Analyzing the Essential Attributes of Nationally Issued COVID-19 Contact Tracing Apps: Open-Source Intelligence Approach and Content Analysis

分析国家发布的 COVID-19 接触者追踪应用程序的关键属性:开源情报方法和内容分析

Weiß, Jan-Patrick; Esdar, Moritz; Hübner, Ursula